X-76428316-C-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_020932.3(MAGEE1):c.386C>G(p.Thr129Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000223 in 1,209,236 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 10 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_020932.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000449 AC: 5AN: 111372Hom.: 0 Cov.: 26 AF XY: 0.0000885 AC XY: 3AN XY: 33890
GnomAD3 exomes AF: 0.000116 AC: 21AN: 180897Hom.: 0 AF XY: 0.000121 AC XY: 8AN XY: 66311
GnomAD4 exome AF: 0.0000200 AC: 22AN: 1097864Hom.: 0 Cov.: 33 AF XY: 0.0000193 AC XY: 7AN XY: 363408
GnomAD4 genome AF: 0.0000449 AC: 5AN: 111372Hom.: 0 Cov.: 26 AF XY: 0.0000885 AC XY: 3AN XY: 33890
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.386C>G (p.T129R) alteration is located in exon 1 (coding exon 1) of the MAGEE1 gene. This alteration results from a C to G substitution at nucleotide position 386, causing the threonine (T) at amino acid position 129 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at